Skip to main content
Clinical Trials/NCT00717106
NCT00717106
Unknown
N/A

Observational Study of the Sleuth Implantable ECG Monitoring System

Transoma Medical8 sites in 1 country250 target enrollmentJuly 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Syncope
Sponsor
Transoma Medical
Enrollment
250
Locations
8
Primary Endpoint
Time to diagnosis
Last Updated
17 years ago

Overview

Brief Summary

The purpose of this study is to obtain information on real-world device performance clinical assessments and clinical outcomes of patients receiving the Sleuth Implantable ECG Monitoring System.

Registry
clinicaltrials.gov
Start Date
July 2008
End Date
TBD
Last Updated
17 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with clinical syndromes or situations at increased risk of cardiac arrhythmias
  • Patients who experience transient symptoms that may suggest a cardiac arrhythmia

Exclusion Criteria

  • Patients that have had a myocardial infarction (MI) \< 30 days prior to implant

Outcomes

Primary Outcomes

Time to diagnosis

Time Frame: one year

Study Sites (8)

Loading locations...

Similar Trials